This company listing is no longer active
Cyclacel Pharmaceuticals 配当金
配当金 基準チェック /06
Cyclacel Pharmaceuticals does not have a record of paying a dividend.
主要情報
n/a
配当利回り
-2.9%
バイバック利回り
| 総株主利回り | -2.9% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当金アップデート
更新なし
Recent updates
決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if UXI's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if UXI's dividend payments have been increasing.
配当利回り対市場
| Cyclacel Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (UXI) | n/a |
| 市場下位25% (DE) | 1.6% |
| 市場トップ25% (DE) | 4.8% |
| 業界平均 (Biotechs) | 1.5% |
| アナリスト予想 (UXI) (最長3年) | n/a |
注目すべき配当: Unable to evaluate UXI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate UXI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate UXI's payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as UXI has not reported any payouts.